Prostate Cancer Treatment Market Size - Global Industry, Share, Analysis, Trends and Forecast 2022 - 2030
CHAPTER 1. Industry Overview of Prostate Cancer Treatment Market
1.1. Definition and Scope
1.1.1. Definition of Prostate Cancer Treatment
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Prostate Cancer Treatment Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Prostate Cancer Treatment Market By Drug Type
1.2.3. Prostate Cancer Treatment Market By Distribution Channel
1.2.4. Prostate Cancer Treatment Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Prostate Cancer Treatment Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Prostate Cancer Treatment Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Cost Structure Analysis
3.9.1. Price Trend of Key Raw Materials
3.9.2. Raw Material Suppliers
3.9.3. Proportion of Manufacturing Cost Structure
3.9.3.1. Raw Material
3.9.3.2. Labor Cost
3.9.3.3. Manufacturing Expense
3.10. Competitive Landscape, 2021
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021
4.2. R&D Status of Major Manufacturers in 2021
CHAPTER 5. Prostate Cancer Treatment Market By Drug Type
5.1. Introduction
5.2. Prostate Cancer Treatment Revenue By Drug Type
5.2.1. Prostate Cancer Treatment Revenue (USD Million) and Forecast, By Drug Type, 2018-2030
5.2.2. Chemotherapy
5.2.2.1. Chemotherapy Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3. Biological Therapy
5.2.3.1. Biological Therapy Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.4. Hormone Therapy
5.2.4.1. Hormone Therapy Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.5. Others
5.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 6. Prostate Cancer Treatment Market By Distribution Channel
6.1. Introduction
6.2. Prostate Cancer Treatment Revenue By Distribution Channel
6.2.1. Prostate Cancer Treatment Revenue (USD Million) and Forecast, By Distribution Channel, 2018-2030
6.2.2. Hospitals Pharmacies
6.2.2.1. Hospitals Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.3. Drug Stores & Retail Pharmacies
6.2.3.1. Drug Stores & Retail Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.4. Online Pharmacies
6.2.4.1. Online Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Prostate Cancer Treatment Market By Country
7.1. North America Prostate Cancer Treatment Market Overview
7.2. U.S.
7.2.1. U.S. Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
7.2.2. U.S. Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
7.3. Canada
7.3.1. Canada Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
7.3.2. Canada Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Prostate Cancer Treatment Market By Country
8.1. Europe Prostate Cancer Treatment Market Overview
8.2. U.K.
8.2.1. U.K. Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
8.2.2. U.K. Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
8.3. Germany
8.3.1. Germany Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
8.3.2. Germany Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
France
8.3.3. France Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
8.3.4. France Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
8.4. Spain
8.4.1. Spain Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
8.4.2. Spain Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
8.5. Rest of Europe
8.5.1. Rest of Europe Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
8.5.2. Rest of Europe Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
8.6. Europe PEST Analysis
CHAPTER 9. Asia Pacific Prostate Cancer Treatment Market By Country
9.1. Asia Pacific Prostate Cancer Treatment Market Overview
9.2. China
9.2.1. China Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
9.2.2. China Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
9.3. Japan
9.3.1. Japan Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
9.3.2. Japan Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
9.4. India
9.4.1. India Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
9.4.2. India Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
9.5. Australia
9.5.1. Australia Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
9.5.2. Australia Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
9.6. South Korea
9.6.1. South Korea Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
9.6.2. South Korea Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
9.7.2. Rest of Asia-Pacific Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Prostate Cancer Treatment Market By Country
10.1. Latin America Prostate Cancer Treatment Market Overview
10.2. Brazil
10.2.1. Brazil Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
10.2.2. Brazil Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
10.3. Mexico
10.3.1. Mexico Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
10.3.2. Mexico Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
10.4.2. Rest of Latin America Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Prostate Cancer Treatment Market By Country
11.1. Middle East & Africa Prostate Cancer Treatment Market Overview
11.2. GCC
11.2.1. GCC Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
11.2.2. GCC Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
11.3. South Africa
11.3.1. South Africa Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
11.3.2. South Africa Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Prostate Cancer Treatment Revenue (USD Million) and Forecast By Drug Type, 2018-2030
11.4.2. Rest of Middle East & Africa Prostate Cancer Treatment Revenue (USD Million) and Forecast By Distribution Channel, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Prostate Cancer Treatment Market
12.1. Prostate Cancer Treatment Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Prostate Cancer Treatment Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Dendreon Pharmaceuticals LLC.
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Million), 2021
13.1.3.2. Dendreon Pharmaceuticals LLC. 2021 Prostate Cancer Treatment Business Regional Distribution
13.1.4. Product/Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. AstraZeneca plc
13.3. Johnson & Johnson Services, Inc.
13.4. Sanofi S.A.
13.5. Abbott Laboratories
13.6. Astellas Pharma Inc.
13.7. Bristol-Myers Squibb Company
13.8. Bayer AG
13.9. AbbVie, Inc.
13.10. Ipsen Pharma
Frequently Asked Questions
What is the size of global prostate cancer treatment market in 2021?
The estimated value of global prostate cancer treatment market in 2021 was accounted to be USD 8,124 Million.
What is the CAGR of global prostate cancer treatment market during forecast period of 2022 to 2030?
The projected CAGR prostate cancer treatment market during the analysis period of 2022 to 2030 is 4.7%.
Which are the key players operating in the market?
The prominent players of the global prostate cancer treatment market are Dendreon Pharmaceuticals LLC., AstraZeneca plc, Johnson & Johnson Services, Inc., Sanofi S.A., Abbott Laboratories, Astellas Pharma Inc., Bristol-Myers Squibb Company, Bayer AG, AbbVie, Inc., and Ipsen Pharma.
Which region held the dominating position in the global prostate cancer treatment market?
Asia-Pacific held the dominating prostate cancer treatment during the analysis period of 2022 to 2030.
Which region registered the fastest growing CAGR for the forecast period of 2022 to 2030?
North America region exhibited fastest growing CAGR for prostate cancer treatment during the analysis period of 2022 to 2030.
What are the current trends and dynamics in the global prostate cancer treatment market?
Increasing occurrence of prostate cancer and cardiovascular diseases, as well as growing geriatric population, drives the growth of global prostate cancer treatment market.
By drug type segment, which sub-segment held the maximum share?
Based on drug type, hormone therapy segment is expected to hold the maximum share prostate cancer treatment market.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
